Already a Bloomberg.com user?
Sign in with the same account.
Don't have an account?
Help! I can't access my account.
April 28 (Bloomberg) -- Bloomberg’s Drew Armstrong examines what Pfizer stands to gain from its $98.7 billion pursuit of AstraZeneca on Bloomberg Television’s “Market Makers.”
On Air Now
Max 250 characters
©2014 Bloomberg L.P. All Rights Reserved. Made in NYC